Armata Pharmaceuticals, Inc. (ARMP)
7.935
-0.24
(-2.88%)
USD |
NYAM |
Jun 01, 16:00
7.935
0.00 (0.00%)
After-Hours: 18:43
Armata Pharmaceuticals Shareholders Equity (Quarterly) : -311.59M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -221.22M |
| Amgen, Inc. | 9.19B |
| Anika Therapeutics, Inc. | 133.90M |
| BioCryst Pharmaceuticals, Inc. | -553.84M |
| Imunon, Inc. | 3.360M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 69.80M |
| Total Liabilities (Quarterly) | 381.39M |
| Debt to Equity Ratio | -1.199 |
| Current Ratio | 0.6443 |
| Net Debt Paydown Yield | -13.17% |